ClinConnect ClinConnect Logo
Search / Trial NCT06349382

CArbohydrate Loading in Aortic Surgery

Launched by UNIVERSITY OF BELGRADE · Mar 29, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the effects of giving patients carbohydrates to drink before undergoing surgery for abdominal aortic aneurysm or Leriche Syndrome. The goal is to see if consuming carbohydrates before surgery can help improve recovery, especially since many patients currently have to fast overnight, which might not be beneficial. The trial is looking for patients who are scheduled for elective surgery and will be the first surgery of the day.

To participate, patients must be able to provide informed consent and should not have certain health conditions, like diabetes or severe obesity, that might complicate the surgery or recovery. If eligible, participants can expect to drink a carbohydrate solution before their surgery and then be monitored to see how it affects their recovery. It's important to note that this study is still recruiting participants, so there is an opportunity for eligible patients to contribute to important research in this area.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Consecutive patients admitted due to elective surgical treatment of abdominal aortic aneurism or Leriche Syndrome.
  • Patients scheduled to be operated on first on a given day, that is, patients whose surgery will be performed first in the morning.
  • Personally signed informed consent.
  • Exclusion Criteria:
  • Patients with diabetes or fasting glucose level above seven mmol/L;
  • Patients with disorders that prolong gastric emptying (gastroesophageal reflux disease, history of gastrointestinal surgery, hiatus hernia or intestinal obstruction);
  • Patients with conditions that could potentially prolong the postoperative recovery (severe physical disability, cognitive impairment, autoimmune diseases, severe infection, significant liver and renal failure, or severe psychiatric/mental disorders);
  • Patients with alcohol/drug abuse
  • Obese patients with obesity class 3 (BMI ≥ 40 kg/m2);
  • Patients undergoing emergent surgery;
  • Patients treated with immunosuppressants and/or steroids in the past three months before surgery;
  • Patients in whom difficult airway is anticipated.

About University Of Belgrade

The University of Belgrade, a leading institution in the field of higher education and research in Serbia, is committed to advancing medical science through rigorous clinical trials. With a focus on innovation and collaboration, the university leverages its diverse expertise to conduct research that addresses critical health challenges. By integrating cutting-edge methodologies and fostering partnerships with healthcare professionals and organizations, the University of Belgrade aims to contribute valuable insights into disease prevention, treatment efficacy, and improved patient outcomes, thereby enhancing the overall quality of care in the region and beyond.

Locations

Belgrade, , Serbia

Patients applied

0 patients applied

Trial Officials

Slobodan Cvetkovic, MD, Ph.D.

Study Chair

Clinic for Vascular and Endovascular Surgery, University Clinical Center of Serbia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported